# Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

> **NCT07564947** · NA · ENROLLING_BY_INVITATION · sponsor: **University of Agriculture, Peshawar** · enrollment: 40 (estimated)

## Conditions studied

- MAFLD
- Fatty Liver
- Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD
- Fatty Liver, Nonalcoholic
- Fatty Liver Disease
- Oxidative Stress
- Inflammation

## Interventions

- **DIETARY_SUPPLEMENT:** Starch Placebo
- **DIETARY_SUPPLEMENT:** Ganoderma lucidum

## Key facts

- **NCT ID:** NCT07564947
- **Lead sponsor:** University of Agriculture, Peshawar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-04-28
- **Primary completion:** 2027-04-20
- **Final completion:** 2027-04-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07564947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07564947, "Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07564947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*